ENTOURAGE HEALTH CORP (ENTG.CA) Forecast, Price Target & Analyst Ratings

TSX-V:ENTGCA2938611001

Current stock price

0.005 CAD
0 (0%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ENTOURAGE HEALTH CORP (ENTG.CA).

Forecast Snapshot

Consensus Price Target

Price Target
N/A
N/A

Next Earnings Forecast

Earnings Estimate
Release Date
May 5, 2025

ChartMill Buy Consensus

Rating
45.71%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
N/A
Upside
N/A
From current price of CA$0.01 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

Analyst Ratings & History

Current Analyst Ratings

ENTG Current Analyst RatingENTG Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

ENTG Historical Analyst RatingsENTG Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
45.71%
ENTG.CA was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about ENTG.CA.
In the previous month the buy percentage consensus was at a similar level.
ENTG.CA was analyzed by 7 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2021-11-18CanaccordFinancialDowngrade Speculative Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 5, 2025

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023
Revenue
YoY % growth
ENTG.CA revenue by date.ENTG.CA revenue by date.
42.272M
43.62%
40.892M
-3.26%
40.713M
-0.44%
EBITDA
YoY % growth
ENTG.CA ebitda by date.ENTG.CA ebitda by date.
-39.787M
44.07%
-40.593M
-2.03%
-19.365M
52.29%
EBIT
YoY % growth
ENTG.CA ebit by date.ENTG.CA ebit by date.
-46.54M
36.50%
-46.445M
0.20%
-19.749M
57.48%
Operating Margin
ENTG.CA operating margin by date.ENTG.CA operating margin by date.
-110.10%-113.58%-48.51%
EPS
YoY % growth
ENTG.CA eps by date.ENTG.CA eps by date.
N/A
-17.24%
N/AN/A

All data in CAD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in CAD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ENTG.CA Yearly Revenue VS EstimatesENTG.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
ENTG.CA Yearly EPS VS EstimatesENTG.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 -0.05 -0.1 -0.15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

ENTOURAGE HEALTH CORP / ENTG.CA Forecast FAQ

When does ENTOURAGE HEALTH CORP (ENTG.CA) report earnings?

ENTOURAGE HEALTH CORP (ENTG.CA) will report earnings on 2025-05-05.

Can you provide the consensus rating for ENTOURAGE HEALTH CORP stock?

The consensus rating for ENTOURAGE HEALTH CORP (ENTG.CA) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.